David H. Donabedian

Statistics

Publications

Citations

405

H-Index

Active since

1998

Affiliations

California Institute of Technology(Current)

Massachusetts General Hospital

Nanotherapeutics (United States)

University of California, Davis

David H. Donabedian is an author at California Institute of Technology specializing in autism spectrum disorders, gut microbiome alterations, and gastrointestinal disease biomarkers.

Publications per year

1998–2022

Publications

Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder

Brittany D. Needham, Mark D. Adame, Gloria Serena et al. · Biological Psychiatry · 2020 · 236 citations · Full text

Life Sciences, Biochemistry, Nutrition +17

Safety and target engagement of an oral small-molecule sequestrant in adolescents with autism spectrum disorder: an open-label phase 1b/2a trial

A. Stewart Campbell, Brittany D. Needham, Christopher R. Meyer et al. · Nature Medicine · 2022 · 105 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +8

Acylation of Pullulan by Ring-Opening of Lactones

David H. Donabedian, Stephen P. McCarthy · Macromolecules · 1998 · 41 citations

Natural Sciences, Chemistry, Materials Science +17

Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder

Brittany D. Needham, Mark D. Adame, Gloria Serena et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 23 citations · Full text

Life Sciences, Biochemistry, Nutrition +17

1–4 of 4